{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T09:12:12Z","timestamp":1790327532947,"version":"4.1.0"},"reference-count":15,"publisher":"Cambridge University Press (CUP)","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can. J. Neurol. Sci."],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Paratonia is an involuntary, variable resistance to passive movement that affects 90%\u2013100% of patients with advanced dementia, interferes with care and contributes to caregiver burden. Botulinum toxin A is a candidate treatment but has no approved indication, and whether community-dwelling caregivers would attend quarterly outpatient treatment has not been characterised. In an online survey of 274 caregivers, 65.3% reported the care-recipient\u2019s paratonia exerted a moderate to extreme impact on their own physical, emotional and mental well-being, and 84.6% reported they would attend an outpatient clinic if treatment were effective. Caregiver willingness suggests the feasibility of clinic-based treatment models.<\/jats:p>","DOI":"10.1017\/cjn.2026.10687","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:52:02Z","timestamp":1790326322000},"page":"1-5","source":"Crossref","is-referenced-by-count":0,"title":["Surmountable Caregiver Barriers to Paratonia Treatment in Community-Dwellers with Dementia: A Cross-Sectional Survey"],"prefix":"10.1017","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5261-2509","authenticated-orcid":false,"given":"Galit","family":"Kleiner","sequence":"first","affiliation":[{"name":"Baycrest Health Sciences"},{"id":[{"id":"https:\/\/ror.org\/03dbr7087","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Toronto Temerty Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Cuppage","sequence":"additional","affiliation":[{"name":"Baycrest Health Sciences"},{"name":"University of Toronto Temerty Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Shnall","sequence":"additional","affiliation":[{"name":"Baycrest Health Sciences"},{"name":"University of Toronto Faculty of Arts & Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Flick","sequence":"additional","affiliation":[{"name":"Baycrest Health Sciences"},{"name":"Centre for Aging and Brain Health Innovation (CABHI)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Omonibo","sequence":"additional","affiliation":[{"name":"Baycrest Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Perri","sequence":"additional","affiliation":[{"name":"Baycrest Health Sciences"},{"name":"University of Toronto Temerty Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"S0317167126106878_ref1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-200691"},{"key":"S0317167126106878_ref12","doi-asserted-by":"publisher","DOI":"10.2196\/17928"},{"key":"S0317167126106878_ref13","doi-asserted-by":"publisher","DOI":"10.3390\/toxins17030102"},{"key":"S0317167126106878_ref10","unstructured":"10. Canadian Institute for Health Information. Dementia in Canada: Dementia in Home and Community Care. Ottawa: CIHI. 2018. https:\/\/www.cihi.ca\/en\/dementia-in-canada\/dementia-care-across-the-health-system\/dementia-in-home-and-community-care. Accessed July 2, 2026."},{"key":"S0317167126106878_ref7","doi-asserted-by":"publisher","DOI":"10.1017\/cjn.2024.46"},{"key":"S0317167126106878_ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2026.106284"},{"key":"S0317167126106878_ref3","doi-asserted-by":"publisher","DOI":"10.1177\/1533317518760594"},{"key":"S0317167126106878_ref15","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-13-110"},{"key":"S0317167126106878_ref6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0114733"},{"key":"S0317167126106878_ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2026.106285"},{"key":"S0317167126106878_ref2","doi-asserted-by":"publisher","DOI":"10.1519\/00139143-200608000-00002"},{"key":"S0317167126106878_ref5","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610211002468"},{"key":"S0317167126106878_ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2025.108786"},{"key":"S0317167126106878_ref9","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.16054"},{"key":"S0317167126106878_ref11","doi-asserted-by":"publisher","DOI":"10.1002\/pmrj.13106"}],"container-title":["Canadian Journal of Neurological Sciences \/ Journal Canadien des Sciences Neurologiques"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0317167126106878","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:52:05Z","timestamp":1790326325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0317167126106878\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":15,"alternative-id":["S0317167126106878"],"URL":"https:\/\/doi.org\/10.1017\/cjn.2026.10687","relation":{},"ISSN":["0317-1671","2057-0155"],"issn-type":[{"value":"0317-1671","type":"print"},{"value":"2057-0155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]}}}